Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors
NCT05490849Phase 1Unknown
- Start
- Oct 2021
- Primary completion
- Jun 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-HX01 in ovarian cancer and pancreatic cancer (PC). Primary endpoint: Visual and standardized uptake values assessment of lesions and biodistribution at 1 year. Status: unknown.
02
Drugs
68Ga-HX01
03
Conditions
ovarian cancerpancreatic cancer (PC)
Beyond the preview
Go deeper on NCT05490849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05490849.